| Literature DB >> 28606177 |
Maeve K Lalor1,2, Laura F Anderson3, Esther L Hamblion4, Andy Burkitt4,5, Jennifer A Davidson3, Helen Maguire6,4, Ibrahim Abubakar3,6, H Lucy Thomas3.
Abstract
BACKGROUND: We estimate the proportion of tuberculosis (TB) in England due to recent household transmission, identify factors associated with being a household transmitter, and investigate the impact that identification of a case has on time to treatment of subsequent cases.Entities:
Keywords: Household; MIRU-VNTR strain typing; Molecular epidemiology; Transmission; Tuberculosis
Mesh:
Year: 2017 PMID: 28606177 PMCID: PMC5469076 DOI: 10.1186/s12916-017-0864-y
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Fig. 1Classification of cases using epidemiological and strain typing data
Fig. 2Flow chart of cases included in study. *One case lives in two households and is thus counted twice in the index case count
Characteristics of index and subsequent cases in households where transmission was not refuted
| Index case ( | Subsequent cases ( | |
|---|---|---|
| Sex | ||
| Male | 358/715 (50.1%) | 481/924 (52.1%) |
| Age (years) | ||
| 0–14 | 97/718 (13.5%) | 364/928 (39.2%) |
| 15–44 | 471/718 (65.6%) | 442/928 (47.6%) |
| 45–64 | 113/718 (15.7%) | 93/928 (10.0%) |
| 65+ | 37/718 (5.2%) | 29/928 (3.1%) |
| Country of birtha | ||
| UK | 210/685 (30.7%) | 411/882 (46.6%) |
| India | 129/685 (18.8%) | 138/882 (15.7%) |
| Pakistan | 78/685 (11.4%) | 68/882 (7.7%) |
| Nepal | 23/685 (3.4%) | 24/882 (2.7%) |
| Somalia | 59/685 (8.6%) | 72/882 (8.2%) |
| Site of disease | ||
| Pulmonary | 538/715 (75.2%) | 603/903 (66.8%) |
aTop five countries of birth by number of cases notified in England between 2010 and 2012
Treatment delay (symptom onset to treatment start) for index cases and subsequent cases in TB households where dates were known
| Treatment delay | |
|---|---|
| Median days (IQR) | |
| Index casea ( | 65 (34–124) |
| All subsequent casesa ( | 40 (18–85) |
| Subsequent symptomaticb cases ( | 61 (31–177) |
| Subsequent asymptomaticb cases ( | 37 (16–70) |
aWhere treatment delay is known (dates to calculate treatment delay are not available for all cases)
bAt index cases’ first contact with healthcare
Fig. 3Diagram showing timing of key events in patient pathway for index cases and subsequent cases stratified according to whether they were symptomatic when the index case first made contact with healthcare
Culture and smear status by age group in household transmitters and all other cases
| Household transmitters | All other cases (non-household transmitters) | |||
|---|---|---|---|---|
| Culture positive | Smear positive | Culture positive | Smear positive | |
| n (%) | n (%) | n (%) | n (%) | |
| Age | ||||
| 0–14 | 29 (42.0) | 16 (23.2) | 265 (25.0) | 58 (5.5) |
| 15–24 | 120 (84.5) | 79 (55.6) | 2422 (68.6) | 741 (21.0) |
| 25–44 | 201 (88.5) | 132 (58.1) | 6806 (62.7) | 1568 (14.5) |
| 45–64 | 77 (92.8) | 53 (63.9) | 2732 (55.7) | 765 (15.6) |
| 65+ | 26 (96.3) | 15 (55.6) | 1846 (58.2) | 456 (14.4) |
| Total | 453 (92.7) | 295 (53.8) | 14,071 (59.8) | 3588 (15.3) |
Univariable and multivariable analysis identifying factors associated with household transmitters
| Household Transmitters | All other cases | Univariable analysis | Multivariable analysis | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | OR | CI |
| aOR | CI |
| |
| Sex | ||||||||||
| Male | 292 | 53.5 | 13,375 | 57.0 | 0.87 | 0.73–1.03 | 0.097 | 0.89 | 0.72–1.10 | 0.273 |
| Age group | ||||||||||
| 0–14 | 69 | 12.6 | 1059 | 4.5 | 3.11 | 2.36–4.11 | <0.0001 | 2.56 | 1.58–4.15 | <0.0001 |
| 15–24 | 142 | 25.9 | 3529 | 15.0 | 1.93 | 1.55–2.38 | 1.47 | 1.14–1.91 | 0.003 | |
| 25–44 | 227 | 41.4 | 10,848 | 46.1 | 1.00 | 1.00 | ||||
| 45–64 | 83 | 15.2 | 4903 | 20.9 | 0.81 | 0.63–1.04 | 1.06 | 0.79–1.41 | 0.719 | |
| 65+ | 27 | 4.9 | 3172 | 13.5 | 0.41 | 0.27–0.61 | 0.51 | 0.32–0.82 | 0.005 | |
| Country of birth/Ethnicity | ||||||||||
| White UK born | 74 | 14.2 | 3308 | 15.0 | 1.40 | 1.02–1.93 | 0.037 | 1.46 | 0.97–2.20 | 0.069 |
| Black Caribbean UK born | 6 | 1.2 | 268 | 1.2 | 1.40 | 0.61–3.25 | 0.427 | 1.21 | 0.51–2.89 | 0.666 |
| Black African UK born | 27 | 5.2 | 335 | 1.5 | 5.06 | 3.22–7.93 | <0.0001 | 2.26 | 1.15–4.44 | 0.018 |
| Indian UK born | 21 | 4.0 | 551 | 2.5 | 2.39 | 1.47–3.90 | <0.0001 | 2.08 | 1.17–3.69 | 0.013 |
| Pakistani UK born | 35 | 6.7 | 655 | 3.0 | 3.35 | 2.23–5.03 | <0.0001 | 2.76 | 1.65–4.62 | <0.0001 |
| Bangladeshi UK born | 5 | 1.0 | 110 | 0.5 | 2.85 | 1.13–7.18 | 0.026 | 2.75 | 0.94–8.03 | 0.064 |
| Other UK born | 13 | 2.5 | 290 | 1.3 | 2.81 | 1.55–5.11 | 0.001 | 1.86 | 0.85–4.09 | 0.121 |
| India | 80 | 15.4 | 5019 | 22.7 | 1.00 | 1.00 | ||||
| Pakistan | 54 | 10.4 | 2939 | 13.3 | 1.15 | 0.81–1.63 | 0.424 | 1.17 | 0.78–1.77 | 0.452 |
| Somalia | 44 | 8.5 | 1186 | 5.4 | 2.33 | 1.60–3.38 | <0.0001 | 1.74 | 1.10–2.76 | 0.019 |
| Bangladesh | 7 | 1.3 | 813 | 3.7 | 0.54 | 0.25–1.17 | 0.120 | 0.81 | 0.34–1.90 | 0.620 |
| Nepal | 15 | 2.9 | 583 | 2.6 | 1.61 | 0.92–2.82 | 0.093 | 1.26 | 0.67–2.35 | 0.471 |
| Nigeria | 12 | 2.3 | 521 | 2.4 | 1.45 | 0.78–2.67 | 0.240 | 1.25 | 0.60–2.61 | 0.557 |
| Zimbabwe | 14 | 2.7 | 456 | 2.1 | 1.93 | 1.08–3.43 | 0.026 | 1.69 | 0.87–3.25 | 0.119 |
| Philippines | 2 | 0.4 | 355 | 1.6 | 0.35 | 0.09–1.44 | 0.147 | 0.30 | 0.04–2.19 | 0.233 |
| Kenya | 5 | 1.0 | 302 | 1.4 | 1.04 | 0.42–2.58 | 0.935 | 1.25 | 0.49–3.19 | 0.635 |
| Sri Lanka | 4 | 0.8 | 286 | 1.3 | 0.88 | 0.32–2.41 | 0.800 | 0.54 | 0.13–2.23 | 0.393 |
| Afghanistan | 6 | 1.2 | 269 | 1.2 | 1.40 | 0.60–3.24 | 0.432 | 1.21 | 0.47–3.08 | 0.693 |
| Eritrea | 8 | 1.5 | 250 | 1.1 | 2.01 | 0.96–4.20 | 0.064 | 1.66 | 0.74–3.73 | 0.221 |
| Romania | 11 | 2.1 | 163 | 0.7 | 4.23 | 2.21–8.10 | <0.0001 | 3.47 | 1.73–6.96 | <0.0001 |
| Poland | 6 | 1.2 | 165 | 0.8 | 2.28 | 0.98–5.31 | 0.055 | 2.12 | 0.88–5.13 | 0.094 |
| Other country | 72 | 13.8 | 3296 | 14.9 | 1.37 | 0.99–1.89 | 0.055 | 1.21 | 0.82–1.80 | 0.329 |
| Lineage | ||||||||||
| Euro-American | 173 | 42.4 | 4494 | 37.2 | 2.31 | 1.55–3.43 | <0.0001 | 1.68 | 1.09–2.59 | 0.018 |
| CAS | 117 | 28.7 | 3535 | 29.3 | 1.98 | 1.32–2.99 | 0.001 | 1.58 | 1.03–2.45 | 0.038 |
| EAI | 29 | 7.1 | 1738 | 14.4 | 1.00 | 1.00 | ||||
| Beijing | 23 | 5.6 | 634 | 5.3 | 2.17 | 1.25–3.79 | 0.006 | 1.66 | 0.93–2.97 | 0.086 |
|
| 2 | 0.5 | 107 | 0.9 | 1.12 | 0.26–4.76 | 0.878 | 0.85 | 0.19–3.72 | 0.830 |
|
| 1 | 0.3 | 49 | 0.4 | 1.22 | 0.16–9.16 | 0.845 | 1.21 | 0.16–9.27 | 0.852 |
|
| 0 | 0.0 | 1 | 0.0 | 1.00 | 1.00 | ||||
| Multiple classifications | 19 | 4.7 | 315 | 2.6 | 3.61 | 2.00–6.53 | <0.0001 | 2.65 | 1.41–4.97 | 0.002 |
| Unknown | 44 | 10.8 | 1198 | 9.9 | 2.20 | 1.37–3.54 | 0.001 | 1.70 | 1.03–2.81 | 0.038 |
CAS Central Asian strain, EAI East African Indian